ArticlePloS one2025
Active expiration reduces hypercapnia in lung failure - results of the prospective interventional ActiveEx study and development of a prototype device for automated application.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigates the efficacy of Intermittent Abdominal Pressure Ventilation (IAPV) and Expiratory Rib Cage Compression (ERCC) in reducing hypercapnia among critically ill, mechanically ventilated patients. It also assesses the feasibility of automating these techniques using a self-developed, ventilator-synchronized device on a dummy.
methodsThis single-arm feasibility study was conducted in two intensive care units at Charité - Universitätsmedizin Berlin, including critically ill patients with hypercapnic lung failure, with additional lab testing at the Technical University of Berlin. Manual IAPV and ERCC were applied to patients, and automation feasibility was tested on a dummy using prototype device. Primary outcomes included changes in tidal volume and partial pressure of carbon dioxide (PaCO2) and device effectiveness at different PEEP levels.
resultsIn nine hypercapnic patients, manual IAPV increased tidal volume from 5.72 to 8.85 mL/ kg predicted bodyweight (p < 0.001, relative effect (CI) 0.93 (0.79-1.06)) and ERCC from 5.79 to 8.13 mL/ kg predicted bodyweight (p < 0.001, relative effect (CI) 0.93 (0.80-1.05)). PaCO2 reduced after 20 minutes with both techniques (IAPV: from 65 to 52 mmHg, p < 0.01, relative effect (CI) 0.15 (0.01-0.28); ERCC: from 61 to 51 mmHg, p= < 0.01, relative effect (CI) 0.22 (0.07-0.37)). A transient decrease in oxygenation was fully and rapidly reversible. The automated device doubled tidal volumes in dummy simulations, with greater effectiveness at higher PEEP-levels.
conclusionManual and automated ventilator-synchronized IAPV and ERCC were associated with improved ventilation. Their potential role in managing hypercapnic respiratory failure-such as in weaning failure, obstructive lung disease, or neuromuscular weakness-remains a subject for future clinical research. German Registry of Clinical Trials (DRKS00027397).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.